BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
See today's BioWorld MedTech
Home
» Brexit could cost U.K. med-tech firms substantial time, money
To read the full story,
subscribe
or
sign in
.
Brexit could cost U.K. med-tech firms substantial time, money
April 12, 2016
By
John Brosky
PARIS – Leaving the European Union will cost the United Kingdom £100 billion pounds (US$142.5 billion) in gross domestic product and 950,000 jobs by 2020, according to the London-based Confederation of British Industry.
BioWorld MedTech